Investors Title Company Q4 2025 Earnings Strong Profitability Amid Flat Revenue Trends NMRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase LODE Q1 2026 Earnings EPS Surpasses Estimates as Company Advances Strategic Initiatives JBHT Q1 2026 Earnings EPS Beats Estimates as Operational Efficiency Drives Performance YEXT Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises Over 2 Travere Therapeutics TVTX Edges Lower 069 as Shares Consolidate Between Support and Resistance Bausch Health Edges Higher Evaluating Key Support and Resistance Levels for BHC Stock JELDWEN Holding Inc JELD Surges 108 to 20 as Support Holds Firm Cardlytics CDLX Slides as Trading Remains Volatile Near Key Support Levels RMTI Q1 2026 Earnings EPS Misses Estimates Stock Declines 2